Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Szilard Pal"'
Autor:
Elhusseiny Mohamed Mahmud Abdelwahab, Judit Rapp, Diana Feller, Veronika Csongei, Szilard Pal, Domokos Bartis, David R. Thickett, Judit Erzsebet Pongracz
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Type 2 alveolar epithelial cells (AT2s) behave as stem cells and show clonal proliferation upon alveolar injury followed by trans-differentiation (TD) into Type 1 alveolar epithelial cells (AT1s). In the present study we identifie
Externí odkaz:
https://doaj.org/article/2daad876bf114e3280c97b389d4aa3d0
Autor:
Kitti Garai, Zoltan Adam, Robert Herczeg, Emese Katai, Tamas Nagy, Szilard Pal, Attila Gyenesei, Judit E. Pongracz, Marta Wilhelm, Krisztian Kvell
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
Studies support that regular physical activity (PA) decelerates senescence-related decline of physiological and molecular parameters in the elderly. We have addressed the other end of this spectrum: healthy and young, inactive individuals participate
Externí odkaz:
https://doaj.org/article/99e5272800f04b7ca72c33ac0abfd48c
Autor:
Zsuzsanna Helyes, Adam Horvath Horvath, Nikolett Szentes, Valeria Tekus, Szilard Pal, Tamás Kálai, Péter Mátyus
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ec86d5819b76ee18394f0eddfce59a1
https://doi.org/10.1124/jpet.122.161660
https://doi.org/10.1124/jpet.122.161660
Autor:
Dávid Sipos, Adorján Varga, Ágnes Kappéter, Bernadett Halda-Kiss, Péter Kása, Szilárd Pál, Béla Kocsis, Zoltán Péterfi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
IntroductionClostridioides difficile infections (CDI) continue to pose a challenge for clinicians. Fecal microbiota transplantation (FMT) is an effective treatment option in CDI. Furthermore, recent and ongoing studies suggest potential benefits of F
Externí odkaz:
https://doaj.org/article/6e5e52bc201a4fa6872c08cc725849af
Publikováno v:
Nanomaterials, Vol 14, Iss 19, p 1561 (2024)
This study presents a reproducible and scalable method for synthesizing silica nanoparticles (SNPs) with controlled sizes below 200 nm, achieved by systematically varying three key reaction parameters: ammonium hydroxide concentration, water concentr
Externí odkaz:
https://doaj.org/article/e16eff90689a4d4990766cbaa2593d2a
Autor:
Istvan Dr. Olajos, Szilárd Pálfay
Publikováno v:
International Journal of Law in Changing World, Vol 3, Iss 1 (2024)
After the end of the COVID 19 outbreak, the authors summarise the measures taken by the European Union to ensure the continuity of food supply and the functioning of the food chain during the outbreak. In addition to the EU measures, the specific mea
Externí odkaz:
https://doaj.org/article/fdefcc623be946c58efbd24cf8a3c229
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 405 (2024)
The flow properties of pellets or granules are crucial for further processing drug dosage forms. Optimal compression or filling of multiparticulate dosage forms into capsules is influenced by forces between discrete particles, which could be partiall
Externí odkaz:
https://doaj.org/article/09afecf5a494451199a437b1fbca47af
Autor:
Barbara Vörös-Horváth, Pavo Živković, Krisztina Bánfai, Judit Bóvári-Biri, Judit Pongrácz, Gábor Bálint, Szilárd Pál, Aleksandar Széchenyi
Publikováno v:
ACS Omega, Vol 7, Iss 4, Pp 3240-3253 (2022)
Externí odkaz:
https://doaj.org/article/00ec0f2bb64040bbb786936b195d81be
Autor:
Adorján Varga, Lilla Makszin, Anita Bufa, Dávid Sipos, Péter Kása, Szilárd Pál, Philip Rosenstiel, Felix Sommer, Béla Kocsis, Zoltán Péterfi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
Background and aimsFaecal microbiota transfer (FMT) has managed to earn its place in the Clostridioides difficile infection (CDI) guidelines by having comparable efficacy and recurrence rate of fidaxomicin. After more than 100 successful FMT administ
Externí odkaz:
https://doaj.org/article/8e1f6287568549c58081701c17f70685
Autor:
Adorján Varga, Béla Kocsis, Dávid Sipos, Péter Kása, Szabolcs Vigvári, Szilárd Pál, Fanni Dembrovszky, Kornélia Farkas, Zoltán Péterfi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
PurposeMetronidazol and vancomycin were long the two best options against Clostridioides (formerly Clostridium) difficile infections (CDI). Now, the cost of new drugs such as fidaxomicin directs us towards alternative treatment options, such as faeca
Externí odkaz:
https://doaj.org/article/245b23804bcc40c18917cb5d7f54ccad